Enexis AB (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:Stockholm
Enexis AB focuses on investing in companies involved in plant-based medical, wellness and industrial applications, notably cannabis and hemp, as permitted by the United Nations Conventions on Drug Narcotics
Average round investment:4.34M USD
Average number per year:1.5
Distribution:
2023 (1)2020 (2)
Portfolio companies:
Tetra Pharm
Alphagreen
Octarine Bio



Mostly invests in:
Denmark (2)
Manufacturing (3)

3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Enexis AB
Name | Criteria | |
---|---|---|
![]() |
Bo Wase
92%
|
|
![]() |
Dhiraj Mukherjee
92%
|
|
![]() |
John Ayton
92%
|
|
![]() |
Redbus Group
92%
|
|
![]() |
Robert Markwick
92%
|
|
![]() |
Ben Holmes
92%
|
|
![]() |
Niels Jørgen Korsholm
92%
|
|
![]() |
Proxy Ventures
92%
|
|
![]() |
Aller Media
92%
|
|
![]() |
ImpactX Capital
92%
|
|